The weekly litigation news digest is live. Subscribe now

IP Verse

Method For Producing Rna Molecule Compositions - EP3319622

The patent EP3319622 was granted to Curevac on Feb 12, 2020. The application was filed on Dec 22, 2016 under application number EP16826337A. The patent is currently recorded with a legal status of "Revoked".

EP3319622

CUREVAC
Application Number
EP16826337A
Filing Date
Dec 22, 2016
Status
Revoked
Mar 31, 2023
Publication Date
Feb 12, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
BIONTECH RNA PHARMACEUTICALSNov 12, 2020THOMANN -

Patent Citations (3) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
EXAMINATIONEP1083232
INTERNATIONAL-SEARCH-REPORTWO2015024669
OPPOSITIONWO2015135558

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents